# A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

> **NCT00001566** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 42 (actual)

## Conditions studied

- Ewing's Sarcoma
- Rhabdomyosarcoma

## Interventions

- **BIOLOGICAL:** therapeutic autologous dendritic cells
- **DRUG:** indinavir sulfate
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00001566
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-12
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2012-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001566, "A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00001566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*